Skip to Main Content (Press Enter)

Logo UNISS
  • ×
  • Home
  • Degrees
  • Courses
  • Jobs
  • People
  • Outputs
  • Organizations
  • Third Mission
  • Expertise & Skills
  • Equipment

Logo UNISS

|

UNIFIND

uniss.it
  • ×
  • Home
  • Degrees
  • Courses
  • Jobs
  • People
  • Outputs
  • Organizations
  • Third Mission
  • Expertise & Skills
  • Equipment
  1. Outputs

Human tissue lead (Pb) levels and amyotrophic lateral sclerosis: a systematic review and meta-analysis of case-control studies.

Academic Article
Publication Date:
2022
Short description:
Human tissue lead (Pb) levels and amyotrophic lateral sclerosis: a systematic review and meta-analysis of case-control studies / Farace, C., Fiorito, G., Pisano, A., Etzi, F., Sabalic, A., Fenu, G., Asara, Y., Solinas, G., Madeddu, R.. - In: NEUROLOGICAL SCIENCES. - ISSN 1590-1874. - 43:(2022), pp. 5851-5859. [10.1007/s10072-022-06237-y]
abstract:
Aim: To combine the current scientific literature evidence and elucidate the differences of lead (Pb) bioaccumulation in human tissues by comparing amyotrophic lateral sclerosis (ALS) patients and healthy controls.

Methods: We systematically searched for case-control studies on the association of Pb levels with ALS, in human cells, tissues, and body fluids (nervous tissue, muscle, blood, cerebrospinal fluid, urine, skin appendages). Then, we performed a meta-analysis for all the tissues in which at least five case-control studies were available: whole blood (9 studies), serum/plasma (5 studies), and cerebrospinal fluid (CSF) (6 studies). Differences between cases and controls were evaluated using standardized mean difference, and combined estimates were derived using random effect maximum likelihood (REML) meta-analyses.

Results: Among 1734 records, we identified 46 full-text studies, of which 14 case-control studies met the meta-analysis inclusion criteria. We found higher Pb levels in ALS cases than controls in blood (standardized mean difference (SMD) = 0.61; 95% confidence interval (CI) 0.20, 1.01; p = 0.003), plasma/serum (SMD = 0.27; 95% CI - 0.16, 0.70; p = 0.26), and CSF (SMD = 0.53; 95% CI - 0.09, 1.15; p = 0.09).

Conclusions: This work provides further evidence of the association between Pb bioaccumulation and ALS in body fluids. The lack of association studies in solid tissues did not allow a robust meta-analysis. Future prospective studies are needed to clarify the causality in the association of Pb bioaccumulation with ALS.
Iris type:
1.1 Articolo in rivista
Keywords:
Amyotrophic lateral sclerosis (ALS); Blood; Cerebrospinal fluid (CSF); Lead (Pb); Meta-analysis; Plasma.
List of contributors:
Farace, C; Fiorito, G; Pisano, A; Etzi, F; Sabalic, A; Fenu, G; Asara, Y; Solinas, G; Madeddu, R.
Authors of the University:
MADEDDU Roberto Beniamino
SOLINAS Maria Giuliana
Handle:
https://iris.uniss.it/handle/11388/294283
Full Text:
https://iris.uniss.it//retrieve/handle/11388/294283/256771/Farace2022_Article_HumanTissueLeadPbLevelsAndAmyo.pdf
Published in:
NEUROLOGICAL SCIENCES
Journal
  • Overview

Overview

URL

https://link.springer.com/content/pdf/10.1007/s10072-022-06237-y.pdf
  • Use of cookies

Powered by VIVO | Designed by Cineca | 26.11.1.0